7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,826.63

+461.00

+0.60%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqGM - Delayed Quote USD

Tevogen Bio Holdings Inc. (TVGN)

5.90 -0.15 (-2.48%)

At close: October 30 at 4:00:00 PM EDT

Loading Chart for TVGN

Chart Range Bar

Interval:

In partnership with ChartIQ

UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC

UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC

Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements

Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements

Tevogen Bio Holdings Inc. Becomes Tevogen Inc.

Tevogen Bio Holdings Inc. Becomes Tevogen Inc.

Tevogen Bio Announces 2026 Annual Meeting of Stockholders

Tevogen Bio Announces 2026 Annual Meeting of Stockholders

Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue

Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization

Letter to Shareholders from CEO Dr. Ryan Saadi

Letter to Shareholders from CEO Dr. Ryan Saadi

Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close

Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close

Tevogen (TVGN) Soars 11% as Firm Gears Up for AI Training Commercialization

Tevogen (TVGN) Soars 11% as Firm Gears Up for AI Training Commercialization

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal

Mobilize your Website

View Site in Mobile | Classic

Share by: